Z

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SZSE:300357

Watchlist Manager
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SZSE:300357
Watchlist
Price: 24.11 CNY -3.13% Market Closed
Market Cap: 12.6B CNY
Have any thoughts about
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd?
Write Note

Relative Value

The Relative Value of one Zhejiang Wolwo Bio-Pharmaceutical Co Ltd stock under the Base Case scenario is 27.4 CNY. Compared to the current market price of 24.11 CNY, Zhejiang Wolwo Bio-Pharmaceutical Co Ltd is Undervalued by 12%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
27.4 CNY
Undervaluation 12%
Relative Value
Price
Z
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
85
vs Industry
13
Median 3Y
23.5
Median 5Y
30.9
Industry
2.6
Forward
12.9
vs History
84
vs Industry
14
Median 3Y
60
Median 5Y
74
Industry
23
Forward
36.2
vs History
80
vs Industry
15
Median 3Y
62.4
Median 5Y
74.8
Industry
17.8
vs History
84
vs Industry
8
Median 3Y
115.6
Median 5Y
146.1
Industry
25.4
vs History
87
vs Industry
16
Median 3Y
10.8
Median 5Y
14
Industry
2.2
vs History
85
vs Industry
13
Median 3Y
22.3
Median 5Y
29.6
Industry
2.8
Forward
11.7
vs History
85
vs Industry
18
Median 3Y
23.4
Median 5Y
31
Industry
5.4
vs History
84
vs Industry
12
Median 3Y
54.6
Median 5Y
68.1
Industry
13.7
Forward
23.8
vs History
84
vs Industry
16
Median 3Y
54.6
Median 5Y
68.1
Industry
17.2
Forward
25.8
vs History
82
vs Industry
17
Median 3Y
59.3
Median 5Y
71.5
Industry
16.5
vs History
90
vs Industry
8
Median 3Y
109.9
Median 5Y
148.2
Industry
19.3
vs History
88
vs Industry
13
Median 3Y
20.4
Median 5Y
25.9
Industry
2

Multiples Across Competitors

Competitors Multiples
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SZSE:300357
12.6B CNY 14.2 40.6 34.8 34.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
756.5B USD 18.5 90.4 48.6 54.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
364.1B USD 4.2 24.8 12 15.6
US
Merck & Co Inc
NYSE:MRK
248.4B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
208.5B CHF 3.6 18.1 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.5 169.4 253.8
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7

See Also

Discover More
Back to Top